Dark | Light
![Pharmashot Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1022473214457348096.png) PharmaShots - Incisive news in 3 shots [@Pharmashot](/creator/twitter/Pharmashot) on x 2267 followers
Created: 2025-07-25 07:31:38 UTC

Matchpoint Therapeutics Partners with Novartis to Develop Oral Covalent Inhibitors for Various Inflammatory Diseases

#matchpointtherapeutics #novartis #advancedcovalentexplorationplatform #covalentinhibitors #inflammatorydiseases #pharma



![](https://pbs.twimg.com/card_img/1948647381953892352/AECBnteX?format=png&name=800x419)

21 engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948647315050524797/c:line.svg)

**Related Topics**
[covalent](/topic/covalent)
[novartis](/topic/novartis)
[$novnsw](/topic/$novnsw)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/Pharmashot/status/1948647315050524797)

Pharmashot Avatar PharmaShots - Incisive news in 3 shots @Pharmashot on x 2267 followers Created: 2025-07-25 07:31:38 UTC

Matchpoint Therapeutics Partners with Novartis to Develop Oral Covalent Inhibitors for Various Inflammatory Diseases

#matchpointtherapeutics #novartis #advancedcovalentexplorationplatform #covalentinhibitors #inflammatorydiseases #pharma

21 engagements

Engagements Line Chart

Related Topics covalent novartis $novnsw stocks healthcare

Post Link

post/tweet::1948647315050524797
/post/tweet::1948647315050524797